GLP-1 drugs, like Ozempic and Wegovy have been associated with a lower risk of cancer in diabetics according to a new study.
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
For patients with type 2 diabetes, taking one of the new GLP-1 drugs, such as Ozempic, is associated with lower risks of ...
The study is the latest evidence to suggest that widely popular diabetes and weight-loss shots may have a role in cancer prevention.
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles.
A new study is showing that the new class of weight loss drugs like Ozempic and Wegovy may help lower the risk of 10 ...
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
The popular class of antidiabetic and weight loss drugs known as GLP-1RAs, which includes Ozempic and Wegovy, has been found ...
A new study shows popular weight-loss drugs and diabetes medications like Ozempic and Wegovy may also help lower the risk of ...
New research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with ...
Losing weight can protect you against cancers related to obesity, a new study finds. Obesity has been linked to higher risk ...
Share on Pinterest A study finds that people with type 2 diabetes who took semaglutide were less likely to develop certain ...